Consent to the Distribution of a New Medicine Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Budesonide 1 mg/mL Spray, nasal suspension Douglas Pharmaceuticals Limited, Henderson, Auckland Amcal Budesonide Nasal Spray Pholcodine 0.2% w/v Linctus Douglas Pharmaceuticals Limited, Mount Wellington, Auckland Amcal Cough Suppressant Double Strength Pholcodine 0.1% w/v Linctus Douglas Pharmaceuticals Limited, Mount Wellington, Auckland Amcal Cough Suppressant Regular Strength Choline theophyllinate 1.5% guaiphenesin 0.75% w/v Syrup Douglas Pharmaceuticals Limited, Mount Wellington, Auckland Amcal Expectorant Syrup Paracetamol 24 mg/mL Suspension, oral Douglas Pharmaceuticals Limited, Mount Wellington, Auckland Amcal Paracetamol Pain & Fever Relief Paracetamol 500 mg Tablet Douglas Pharmaceuticals Limited, Henderson, Auckland Amcal Paracetamol Pain Relief Dolomite 400 mg Tablet, chewable Viminco A/S., Skaelskor, Denmark Frutin Paracetamol 2.4% w/v Suspension, oral PSM Healthcare Limited, Wiri, Auckland Pharmacare Paramol Junior Suspension Pholcodine 1 mg/mL Linctus PSM Healthcare Limited, Wiri, Auckland Pholcodine Linctus Pholcodine 2 mg/mL Linctus PSM Healthcare Limited, Wiri, Auckland Pholcodine Strong Linctus Dated this 7th day of April 1999. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.